DMPA-SC Access Collaborative Brief

Subcutaneous DMPA (DMPA-SC, brand name Sayana Press) is an innovative injectable contraceptive that can dramatically expand access and choice for women. A new initiative led by PATH and John Snow Inc., the Subcutaneous DMPA Access Collaborative is working with ministries of health and partners across sectors to strengthen scale-up and build toward a robust global market for the product. For more information, visit the DMPA-SC Access Collaborative page or email FPoptions@path.org.

Publication date: January 2018

Available materials

  1. English

    1. Subcutaneous DMPA Access Collaborative brief 217.7 KB PDF

      Hard copies are not available.

  2. French

    1. Subcutaneous DMPA Access Collaborative Brief [French] 201.9 KB PDF

      Hard copies are not available.